- Home
- Drug And Medication Industry
- Pharmacodynamics Market and Forecasts, May 2013
Industries
- Drug and Medication (202)
- Pathology (68)
- Biopharmaceutical (21)
- Drug Discovery and Development (21)
- Pharmaceutical (12)
-
- Biotechnology (11)
- Drug Delivery Technology (7)
- Diagnostics (6)
- Generic Drug (6)
- Genomics (5)
- Fruit and Vegetable (4)
- Nanotechnology (4)
- Biological Therapy (3)
- Blood Supply, Tissue Banking and Transplantation (3)
- Mineral Mining (3)
- Ophthalmic Devices (3)
- Advanced Material (2)
- Agriculture (1)
- Dairy Products and Egg (1)
- Environmental Services (1)
Top countries
Publication dates
All regions
data types
- All
- Company Data (433)
- Industry Data
- Country Data (23)
Pharmacodynamics Market and Forecasts, May 2013
You might be interested in: clinical trial, pharmacokinetics, cancer, more »
industry reports
country reports
The Canadian Clinical Study Industry Brief
- Industry report
- September 2011
- 41 pages
... Of the pre-clinical studies: Finding from the phamacokinetics, pharmacodynamic and toxicology studies should be extrapolated to assess the drug S potential safety in humans. Any adverse effects observed ...
- Industries: Drug Discovery and Development
- Countries: Canada
Drug Development in The United States : Innovation and Technology Trends
- Industry report
- January 2011
- 26 pages
... Using mathematical/statistical modeling and simulation technologies to integrate drug specific pharmacokinetic(pk), pharmacodynamic (pd) and disease-specific information to improve the efficiency ...
- Industries: Drug Discovery and Development
- Countries: United States
U.S. Drug Development Market : Innovation and Technology Trends
- Industry report
- January 2011
- 26 pages
... Using mathematical/statistical modeling and simulation technologies to integrate drug specific pharmacokinetic(pk), pharmacodynamic (pd) and disease-specific information to improve the efficiency ...
- Industries: Drug Discovery and Development
- Countries: United States
Drug and Medication Business
- Industry report
- February 2011
- 49 pages
... The mechanisms of resistance identify ways to combat antimicrobial resistance review principles of pharmacokinetics and pharmacodynamics introduce antimicrobial stewardship mechanisms of resistance enzymatic ...
- Industries: Drug and Medication
Pharmaceutical Sector in The United States
- Industry report
- November 2011
- 26 pages
... Not occur at all Toxicity may not increase with dose Endpoint may no longer be appropriate Mtd Optimal biological dose (obd) pharmacodynamics, pharmacokinetics and immunogenicity ...
- Industries: Pathology
- Countries: United States
The Irish Drug and Medication Industry Brief
- Industry report
- January 2011
- 13 pages
... To the overall antidepressant effect. pharmacodynamic effects suppression of rapid eye movement (rem) sleep is considered a predictor of antidepressant activity. Like tricyclic antidepressants, other ssris and mao ...
- Industries: Drug and Medication
- Countries: Ireland
Drug and Medication Market Brief
- Industry report
- May 2011
- 14 pages
... And other oral anticoagulants. Other concomitant therapies no clinically significant pharmacokinetic or pharmacodynamic interactions were observed when apixaban was co-administered with atenolol ...
- Industries: Drug and Medication
Drug and Medication Industry Brief
- Industry report
- March 2012
- 12 pages
- by Corporation
... Combinations maois (non-selective as well as selective a (moclobemide)) - risk of Serotonin syndrome (See section 4.3). Ot interval prolongation pharmacokinetic and pharmacodynamic studies between ...
- Industries: Drug and Medication
Drug and Medication Sector in Ireland
- Industry report
- July 2012
- 12 pages
... Debrisoquine oxidation (cyp2d6). For cyp2c19, as a precaution, an initial dose of 10 mg should be considered for known poor metabolisers (see section 4.2). Pharmacokinetic / pharmacodynamic relationship there is no clear ...
- Industries: Drug and Medication
- Countries: Ireland
Drug and Medication Market in Europe
- Industry report
- April 2011
- 17 pages
... Triethylcitrate) in the european market, no significant risk of dose-dumping due to alcohol use was identified. However, for all of these products, a pharmacodynamic interaction may occur and should be mentioned ...
- Industries: Drug and Medication
- Countries: Europe, United Kingdom
Reportlinker.com © Copyright 2013. All rights reserved.
